The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NK Cells-Global Market Insights and Sales Trends 2025
Synopsis
The global NK Cells market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NK Cells in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling NK Cells market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for NK Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the NK Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NK Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NK Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NK Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NK Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NK Cells covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global NK Cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
Global NK Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NK Cells market, Segment by Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global NK Cells market, by Application
Cancer
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of NK Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global NK Cells market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NK Cells in various end use industries. The expanding demands from the Cancer, Cardiovascular Diseases and Others,, are propelling NK Cells market. Mogamulizumab, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lorvotuzumab Mertansine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for NK Cells market, driven by demand from China, the second largest economy with some signs of stabilising, the NK Cells market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NK Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NK Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NK Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NK Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NK Cells covered in this report include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc.
The global NK Cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
Global NK Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NK Cells market, Segment by Type:
Mogamulizumab
Lorvotuzumab Mertansine
Others
Global NK Cells market, by Application
Cancer
Cardiovascular Diseases
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of NK Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 NK Cells Market Overview
1.1 NK Cells Product Overview
1.2 NK Cells Market Segment by Type
1.2.1 Mogamulizumab
1.2.2 Lorvotuzumab Mertansine
1.2.3 Others
1.3 Global NK Cells Market Size by Type
1.3.1 Global NK Cells Market Size Overview by Type (2018-2029)
1.3.2 Global NK Cells Historic Market Size Review by Type (2018-2023)
1.3.3 Global NK Cells Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America NK Cells Sales Breakdown by Type (2018-2023)
1.4.2 Europe NK Cells Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific NK Cells Sales Breakdown by Type (2018-2023)
1.4.4 Latin America NK Cells Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa NK Cells Sales Breakdown by Type (2018-2023)
2 Global NK Cells Market Competition by Company
2.1 Global Top Players by NK Cells Sales (2018-2023)
2.2 Global Top Players by NK Cells Revenue (2018-2023)
2.3 Global Top Players by NK Cells Price (2018-2023)
2.4 Global Top Manufacturers NK Cells Manufacturing Base Distribution, Sales Area, Product Type
2.5 NK Cells Market Competitive Situation and Trends
2.5.1 NK Cells Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by NK Cells Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NK Cells as of 2022)
2.7 Date of Key Manufacturers Enter into NK Cells Market
2.8 Key Manufacturers NK Cells Product Offered
2.9 Mergers & Acquisitions, Expansion
3 NK Cells Status and Outlook by Region
3.1 Global NK Cells Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global NK Cells Historic Market Size by Region
3.2.1 Global NK Cells Sales in Volume by Region (2018-2023)
3.2.2 Global NK Cells Sales in Value by Region (2018-2023)
3.2.3 Global NK Cells Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global NK Cells Forecasted Market Size by Region
3.3.1 Global NK Cells Sales in Volume by Region (2024-2029)
3.3.2 Global NK Cells Sales in Value by Region (2024-2029)
3.3.3 Global NK Cells Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global NK Cells by Application
4.1 NK Cells Market Segment by Application
4.1.1 Cancer
4.1.2 Cardiovascular Diseases
4.1.3 Others
4.2 Global NK Cells Market Size by Application
4.2.1 Global NK Cells Market Size Overview by Application (2018-2029)
4.2.2 Global NK Cells Historic Market Size Review by Application (2018-2023)
4.2.3 Global NK Cells Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America NK Cells Sales Breakdown by Application (2018-2023)
4.3.2 Europe NK Cells Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific NK Cells Sales Breakdown by Application (2018-2023)
4.3.4 Latin America NK Cells Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa NK Cells Sales Breakdown by Application (2018-2023)
5 North America NK Cells by Country
5.1 North America NK Cells Historic Market Size by Country
5.1.1 North America NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America NK Cells Sales in Volume by Country (2018-2023)
5.1.3 North America NK Cells Sales in Value by Country (2018-2023)
5.2 North America NK Cells Forecasted Market Size by Country
5.2.1 North America NK Cells Sales in Volume by Country (2024-2029)
5.2.2 North America NK Cells Sales in Value by Country (2024-2029)
6 Europe NK Cells by Country
6.1 Europe NK Cells Historic Market Size by Country
6.1.1 Europe NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe NK Cells Sales in Volume by Country (2018-2023)
6.1.3 Europe NK Cells Sales in Value by Country (2018-2023)
6.2 Europe NK Cells Forecasted Market Size by Country
6.2.1 Europe NK Cells Sales in Volume by Country (2024-2029)
6.2.2 Europe NK Cells Sales in Value by Country (2024-2029)
7 Asia-Pacific NK Cells by Region
7.1 Asia-Pacific NK Cells Historic Market Size by Region
7.1.1 Asia-Pacific NK Cells Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific NK Cells Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific NK Cells Sales in Value by Region (2018-2023)
7.2 Asia-Pacific NK Cells Forecasted Market Size by Region
7.2.1 Asia-Pacific NK Cells Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific NK Cells Sales in Value by Region (2024-2029)
8 Latin America NK Cells by Country
8.1 Latin America NK Cells Historic Market Size by Country
8.1.1 Latin America NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America NK Cells Sales in Volume by Country (2018-2023)
8.1.3 Latin America NK Cells Sales in Value by Country (2018-2023)
8.2 Latin America NK Cells Forecasted Market Size by Country
8.2.1 Latin America NK Cells Sales in Volume by Country (2024-2029)
8.2.2 Latin America NK Cells Sales in Value by Country (2024-2029)
9 Middle East and Africa NK Cells by Country
9.1 Middle East and Africa NK Cells Historic Market Size by Country
9.1.1 Middle East and Africa NK Cells Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa NK Cells Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa NK Cells Sales in Value by Country (2018-2023)
9.2 Middle East and Africa NK Cells Forecasted Market Size by Country
9.2.1 Middle East and Africa NK Cells Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa NK Cells Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Chipscreen Biosciences
10.1.1 Chipscreen Biosciences Company Information
10.1.2 Chipscreen Biosciences Introduction and Business Overview
10.1.3 Chipscreen Biosciences NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Chipscreen Biosciences NK Cells Products Offered
10.1.5 Chipscreen Biosciences Recent Development
10.2 Affimed NV
10.2.1 Affimed NV Company Information
10.2.2 Affimed NV Introduction and Business Overview
10.2.3 Affimed NV NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Affimed NV NK Cells Products Offered
10.2.5 Affimed NV Recent Development
10.3 Altor BioScience
10.3.1 Altor BioScience Company Information
10.3.2 Altor BioScience Introduction and Business Overview
10.3.3 Altor BioScience NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Altor BioScience NK Cells Products Offered
10.3.5 Altor BioScience Recent Development
10.4 Innate Pharma
10.4.1 Innate Pharma Company Information
10.4.2 Innate Pharma Introduction and Business Overview
10.4.3 Innate Pharma NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Innate Pharma NK Cells Products Offered
10.4.5 Innate Pharma Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Takeda NK Cells Products Offered
10.5.5 Takeda Recent Development
10.6 Sorrento Therapeutics
10.6.1 Sorrento Therapeutics Company Information
10.6.2 Sorrento Therapeutics Introduction and Business Overview
10.6.3 Sorrento Therapeutics NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sorrento Therapeutics NK Cells Products Offered
10.6.5 Sorrento Therapeutics Recent Development
10.7 NantKwest
10.7.1 NantKwest Company Information
10.7.2 NantKwest Introduction and Business Overview
10.7.3 NantKwest NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.7.4 NantKwest NK Cells Products Offered
10.7.5 NantKwest Recent Development
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Company Information
10.8.2 Bristol-Myers Squibb Introduction and Business Overview
10.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bristol-Myers Squibb NK Cells Products Offered
10.8.5 Bristol-Myers Squibb Recent Development
10.9 NKT
10.9.1 NKT Company Information
10.9.2 NKT Introduction and Business Overview
10.9.3 NKT NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.9.4 NKT NK Cells Products Offered
10.9.5 NKT Recent Development
10.10 Henry Ford Health Services
10.10.1 Henry Ford Health Services Company Information
10.10.2 Henry Ford Health Services Introduction and Business Overview
10.10.3 Henry Ford Health Services NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Henry Ford Health Services NK Cells Products Offered
10.10.5 Henry Ford Health Services Recent Development
10.11 Fortress Biotech
10.11.1 Fortress Biotech Company Information
10.11.2 Fortress Biotech Introduction and Business Overview
10.11.3 Fortress Biotech NK Cells Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Fortress Biotech NK Cells Products Offered
10.11.5 Fortress Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 NK Cells Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 NK Cells Industrial Chain Analysis
11.4 NK Cells Market Dynamics
11.4.1 NK Cells Industry Trends
11.4.2 NK Cells Market Drivers
11.4.3 NK Cells Market Challenges
11.4.4 NK Cells Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 NK Cells Distributors
12.3 NK Cells Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
